GEODE CAPITAL MANAGEMENT, LLC

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$18,093,898	1,552,870	+47,253	+3.1%	$11.65	Q4 2025
30 Sep 2025	0%	+0%	$15,134,147	1,505,617	+163,230	+12%	$10.05	Q3 2025
30 Jun 2025	0%	+0%	$23,427,118	1,342,387	+81,910	+6.5%	$17.45	Q2 2025
31 Mar 2025	0%	+0%	$15,860,722	1,260,477	+22,321		$12.58	Q1 2025
31 Dec 2024	0%	+0%	$13,066,159	1,238,156	+3,351	+0.27%	$10.55	Q4 2024
30 Sep 2024	0%	+0%	$17,908,673	1,234,805	+38,927	+3.3%	$14.50	Q3 2024
30 Jun 2024	0%	+0%	$10,178,456	1,195,878	+319,207	+36%	$8.51	Q2 2024
31 Mar 2024	0%	+0%	$8,961,353	876,671	+11,802	+1.4%	$10.22	Q1 2024
31 Dec 2023	0%	+0%	$4,740,137	864,869	+61,528	+7.7%	$5.48	Q4 2023
30 Sep 2023	0%	+0%	$3,037,127	803,341	+149,746	+23%	$3.78	Q3 2023
30 Jun 2023	0%	+0%	$4,379,086	653,595	+249,991	+62%	$6.70	Q2 2023
31 Mar 2023	0%	+0%	$2,627,462	403,604	+71,408	+21%	$6.51	Q1 2023
31 Dec 2022	0%	+0%	$2,833,000	332,196	+107,812	+48%	$8.53	Q4 2022
30 Sep 2022	0%	+0%	$1,184,000	224,384	+732	+0.33%	$5.28	Q3 2022
30 Jun 2022	0%	-0%	$948,000	223,652	-138,988	-38%	$4.24	Q2 2022
31 Mar 2022	0%	-0%	$1,272,000	362,640	-29,472	-7.5%	$3.51	Q1 2022
31 Dec 2021	0%	+0%	$2,611,000	392,112	+207,000	+112%	$6.66	Q4 2021
30 Sep 2021	0%	-0%	$1,847,000	185,112	-35,576	-16%	$9.98	Q3 2021
30 Jun 2021	0%	+0%	$6,817,000	220,688	+2,067	+0.95%	$30.89	Q2 2021
31 Mar 2021	0%	+0%	$9,538,000	218,621	+199,391	+1037%	$43.63	Q1 2021
31 Dec 2020	0%	+0%	$891,000	19,230	+19,230	NEW	$46.33	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.